XML 18 R8.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Condensed Statements of Shareholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Sep. 30, 2020   5,916      
Beginning balance at Sep. 30, 2020 $ 45,523 $ 5,916 $ 10,736 $ 42,339 $ (13,468)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Comprehensive income (loss) 2,452     1,756 696
Performance and restricted share expense 378   378    
Share transactions under equity based plans (in shares)   73      
Share transactions under equity based plans (16) $ 73 (89)    
Ending balance (in shares) at Jun. 30, 2021   5,989      
Ending balance at Jun. 30, 2021 48,337 $ 5,989 11,025 44,095 (12,772)
Beginning balance (in shares) at Mar. 31, 2021   5,989      
Beginning balance at Mar. 31, 2021 47,708 $ 5,989 10,940 43,841 (13,062)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Comprehensive income (loss) 544     254 290
Performance and restricted share expense 85   85    
Ending balance (in shares) at Jun. 30, 2021   5,989      
Ending balance at Jun. 30, 2021 48,337 $ 5,989 11,025 44,095 (12,772)
Beginning balance (in shares) at Sep. 30, 2021   5,987      
Beginning balance at Sep. 30, 2021 49,622 $ 5,987 11,118 41,596 (9,079)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Comprehensive income (loss) (2,857)     (2,720) (137)
Performance and restricted share expense 309   309    
Share transactions under equity based plans (in shares)   53      
Share transactions under equity based plans (106) $ 53 (159)    
Ending balance (in shares) at Jun. 30, 2022   6,040      
Ending balance at Jun. 30, 2022 46,968 $ 6,040 11,268 38,876 (9,216)
Beginning balance (in shares) at Mar. 31, 2022   6,040      
Beginning balance at Mar. 31, 2022 49,748 $ 6,040 11,264 41,544 (9,100)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Comprehensive income (loss) (2,784)     (2,668) (116)
Performance and restricted share expense 4   4    
Ending balance (in shares) at Jun. 30, 2022   6,040      
Ending balance at Jun. 30, 2022 $ 46,968 $ 6,040 $ 11,268 $ 38,876 $ (9,216)